PAVmed Other Current Assets from 2010 to 2024

PAVMZ Stock  USD 0.02  0.01  47.57%   
PAVmed Series Other Current Assets yearly trend continues to be fairly stable with very little volatility. Other Current Assets will likely drop to about 3.6 M in 2024. Other Current Assets is assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories. View All Fundamentals
 
Other Current Assets  
First Reported
2015-03-31
Previous Quarter
3.5 M
Current Value
1.3 M
Quarterly Volatility
1.6 B
 
Yuan Drop
 
Covid
Check PAVmed Series financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PAVmed Series' main balance sheet or income statement drivers, such as Interest Expense of 559.5 K, Selling General Administrative of 32.5 M or Other Operating Expenses of 74.8 M, as well as many indicators such as Price To Sales Ratio of 11.54, Dividend Yield of 3.0E-4 or Days Sales Outstanding of 14.05. PAVmed financial statements analysis is a perfect complement when working with PAVmed Series Valuation or Volatility modules.
  
Check out the analysis of PAVmed Series Correlation against competitors.

Latest PAVmed Series' Other Current Assets Growth Pattern

Below is the plot of the Other Current Assets of PAVmed Series Z over the last few years. It is assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories. PAVmed Series' Other Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PAVmed Series' overall financial position and show how it may be relating to other accounts over time.
Other Current Assets10 Years Trend
Pretty Stable
   Other Current Assets   
       Timeline  

PAVmed Other Current Assets Regression Statistics

Arithmetic Mean21,886,843,114
Geometric Mean252,148
Coefficient Of Variation387.27
Mean Deviation40,852,954,251
Median155,490
Standard Deviation84,762,220,445
Sample Variance7184634014.7T
Range328.3B
R-Value0.12
Mean Square Error7618835583.3T
R-Squared0.02
Significance0.66
Slope2,345,218,252
Total Sum of Squares100584876205.8T

PAVmed Other Current Assets History

20243.6 M
20233.8 M
20223.9 M
20215.2 M
20201.7 M
2019328.3 B
2018238 K

About PAVmed Series Financial Statements

PAVmed Series investors use historical fundamental indicators, such as PAVmed Series' Other Current Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in PAVmed Series. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Current Assets3.8 M3.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for PAVmed Stock Analysis

When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.